MedPath

A Multi-Site Post Marketing Surveillance Study for Systane in Indian Patients

Phase 4
Completed
Conditions
Moderate to Severe Dry Eye
Interventions
Other: Systane
Registration Number
NCT01311609
Lead Sponsor
Alcon Research
Brief Summary

This study is a multi-site, unmasked PMS Study. The purpose of the study is to evaluate the physical effects of Systane Lubricant Eye Drops.

Detailed Description

This study is a multi-site, unmasked PMS Study. The purpose of the study is to evaluate the physical effects of Systane Lubricant Eye Drops. The assessed effects include: corneal and conjunctival staining, and ocular signs and symptoms. This is a two week prospective study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • 18 years of age or older, of both sexes, and any race.
  • Willing and able to make all required visits and follow study instructions.
  • A sodium fluorescein corneal staining sum of >/ 3 in either eye. A best-corrected visual acuity of 0.6 log MAR or better in each eye as assessed during an ETDRS chart
Read More
Exclusion Criteria
  • A history or evidence of ocular or intraocular surgery in either eye within the past 6 months.
  • Lasik patients can be included if Lasik surgery was > 6 months prior to the initiation of the study.
  • A history of intolerance or hypersensitivity to any component of the study medications.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SystaneSystaneSystane Lubricant Eye Drops
Primary Outcome Measures
NameTimeMethod
Best-corrected visual acuityVisit 2 (Week 2) - change from baseline
Corneal StainingVisit 2 (Week 2) - change from baseline
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath